Structural and mechanistic comparison of the Cyclopropane Mycolic Acid Synthases (CMAS) protein family of Mycobacterium tuberculosis
Tuberculosis (TB) is a chronic disease caused by the bacillus Mycobacterium tuberculosis(Mtb) and remains a leading cause of mortality worldwide. The bacteria has an external wall which protects it from being killed, and the enzymes involved in the biosynthesis of the cell wall components have been...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier B.V.
2018
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12985caa a22013577a 4500 | ||
|---|---|---|---|
| 001 | PAPER-17050 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204810.0 | ||
| 008 | 190410s2018 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-85028689177 | |
| 024 | 7 | |2 cas |a bicarbonate, 144-55-8, 71-52-3; cyclopropane, 75-19-4; methyltransferase, 9033-25-4; mixed function oxidase, 9040-60-2; Bacterial Proteins; Bicarbonates; cyclopropane; Cyclopropanes; Methyltransferases; Mixed Function Oxygenases; mma4 protein, Mycobacterium tuberculossis | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a BBRCA | ||
| 100 | 1 | |a Defelipe, L.A. | |
| 245 | 1 | 0 | |a Structural and mechanistic comparison of the Cyclopropane Mycolic Acid Synthases (CMAS) protein family of Mycobacterium tuberculosis |
| 260 | |b Elsevier B.V. |c 2018 | ||
| 270 | 1 | 0 | |m Turjanski, A.G.; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes, Argentina; email: adrian@qi.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Organization, W.H., Others, Global tuberculosis report 2016 (2016), http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf; Caminero, J.A., Sotgiu, G., Zumla, A., Migliori, G.B., Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis (2010) Lancet Infect. Dis., 10, pp. 621-629 | ||
| 504 | |a Voskuil, M.I., Bartek, I.L., Visconti, K., Schoolnik, G.K., The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species (2011) Front. Microbiol., 2 | ||
| 504 | |a Demissie, A., Leyten, E.M.S., Abebe, M., Wassie, L., Aseffa, A., Abate, G., Fletcher, H., Doherty, T.M., VACSEL Study Group, Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis (2006) Clin. Vaccine Immunol., 13, pp. 179-186 | ||
| 504 | |a Abdallah, A.M., van Pittius, N.C.G., Champion, P.A.D., Cox, J., Luirink, J., Vandenbroucke-Grauls, C.M., Appelmelk, B.J., Bitter, W., Type VII secretion—mycobacteria show the way (2007) Nat. Rev. Microbiol., 5, pp. 883-891 | ||
| 504 | |a Marrakchi, H., Lanéelle, M.-A., Daffé, M., Mycolic acids: structures, biosynthesis, and beyond (2014) Chem. Biol., 21, pp. 67-85 | ||
| 504 | |a Defelipe, L.A., Do Porto, D.F., Pereira Ramos, P.I., Nicolás, M.F., Sosa, E., Radusky, L., Lanzarotti, E., Marti, M.A., A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis (2016) Tuberculosis, 97, pp. 181-192 | ||
| 504 | |a Yuan, Y., Lee, R.E., Besra, G.S., Belisle, J.T., Barry, C.E., Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis (1995) Proc. Natl. Acad. Sci., 92, pp. 6630-6634 | ||
| 504 | |a Glickman, M.S., Cahill, S.M., Jacobs, W.R., The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase (2001) J. Biol. Chem., 276, pp. 2228-2233 | ||
| 504 | |a Glickman, M.S., The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the α-mycolic acid (2003) J. Biol. Chem., 278, pp. 7844-7849 | ||
| 504 | |a Barkan, D., Rao, V., Sukenick, G.D., Glickman, M.S., Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates (2010) J. Bacteriol., 192, pp. 3661-3668 | ||
| 504 | |a Glickman, M.S., Cox, J.S., Jacobs, W.R., Jr., A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis (2000) Mol. Cell., 5, pp. 717-727 | ||
| 504 | |a Yuan, Y., Crane, D.C., Musser, J.M., Sreevatsan, S., Barry, C.E., MMAS-1, the branch point between cis-and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis (1997) J. Biol. Chem., 272, pp. 10041-10049 | ||
| 504 | |a Yuan, Y., Barry, C.E., A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis (1996) Proc. Natl. Acad. Sci., 93, pp. 12828-12833 | ||
| 504 | |a Behr, M.A., Schroeder, B.G., Brinkman, J.N., Slayden, R.A., Barry, C.E., A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927 (2000) J. Bacteriol., 182, pp. 3394-3399 | ||
| 504 | |a Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., Sali, A., Protein structure modeling with MODELLER (2008) Structural Proteomics, pp. 145-159. , Springer | ||
| 504 | |a Ruiz-Carmona, S., Alvarez-Garcia, D., Foloppe, N., Garmendia-Doval, A.B., Juhos, S., Schmidtke, P., Barril, X., Morley, S.D., rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids (2014) PLoS Comput. Biol., 10, p. e1003571 | ||
| 504 | |a David Morley, S., Afshar, M., Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock ® (2004) J. Comput. Aided Mol. Des., 18, pp. 189-208 | ||
| 504 | |a Case, D.A., Babin, V., Berryman, J., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E., (2014), Iii, T.A. Darden, R.E. Duke, H. Gohlke, Others, amber 14; Wang, J., Wolf, R.M., Caldwell, J.W., Kollman, P.A., Case, D.A., Development and testing of a general amber force field (2004) J. Comput. Chem., 25, pp. 1157-1174 | ||
| 504 | |a Salomon-Ferrer, R., Götz, A.W., Poole, D., Le Grand, S., Walker, R.C., Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. explicit solvent particle mesh Ewald (2013) J. Chem. Theory Comput., 9, pp. 3878-3888 | ||
| 504 | |a Elstner, M., The SCC-DFTB method and its application to biological systems (2006) Theor. Chem. Acc., 116, pp. 316-325 | ||
| 504 | |a de M Seabra, G., Walker, R.C., Elstner, M., Case, D.A., Roitberg, A.E., Implementation of the SCC-DFTB method for hybrid QM/MM simulations within the amber molecular dynamics package (2007) J. Phys. Chem. A, 111, pp. 5655-5664 | ||
| 504 | |a Loncharich, R.J., Brooks, B.R., Pastor, R.W., Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N′-methylamide (1992) Biopolymers, 32, pp. 523-535 | ||
| 504 | |a Jarzynski, C., Nonequilibrium equality for free energy differences (1997) Phys. Rev. Lett., 78, p. 2690 | ||
| 504 | |a Defelipe, L.A., Lanzarotti, E., Gauto, D., Marti, M.A., Turjanski, A.G., Protein topology determines cysteine oxidation fate: the case of sulfenyl amide formation among protein families (2015) PLoS Comput. Biol., 11. , e1004051–e1004051 | ||
| 504 | |a Ramirez, C.L., Zeida, A., Jara, G.E., Roitberg, A.E., Marti, M.A., Improving efficiency in SMD simulations through a hybrid differential relaxation algorithm (2014) J. Chem. Theory Comput., 10, pp. 4609-4617 | ||
| 504 | |a Lanzarotti, E., Biekofsky, R.R., Estrin, D.A., Marti, M.A., Turjanski, A.G., Aromatic–aromatic interactions in proteins: beyond the dimer (2011) J. Chem. Inf. Model, 51, pp. 1623-1633 | ||
| 504 | |a Huang, C.-C., Smith, C.V., Glickman, M.S., Jacobs, W.R., Sacchettini, J.C., Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis (2002) J. Biol. Chem., 277, pp. 11559-11569 | ||
| 504 | |a Liao, R.-Z., Georgieva, P., Yu, J.-G., Himo, F., Mechanism of mycolic acid cyclopropane synthase: a theoretical study (2011) Biochemistry, 50, pp. 1505-1513 | ||
| 504 | |a Iwig, D.F., Uchida, A., Stromberg, J.A., Booker, S.J., The activity of Escherichia coli cyclopropane fatty acid synthase depends on the presence of bicarbonate (2005) J. Am. Chem. Soc., 127, pp. 11612-11613 | ||
| 504 | |a Iwig, D.F., Grippe, A.T., McIntyre, T.A., Booker, S.J., Isotope and elemental effects indicate a rate-limiting methyl transfer as the initial step in the reaction catalyzed by Escherichia coli cyclopropane fatty acid synthase (2004) Biochemistry, 43, pp. 13510-13524 | ||
| 504 | |a Hare, S.R., Pemberton, R.P., Tantillo, D.J., Navigating past a fork in the road: carbocation-π interactions can manipulate dynamic behavior of reactions facing post-transition-state bifurcations (2017) J. Am. Chem. Soc. | ||
| 504 | |a López, E.D., Arcon, J.P., Gauto, D.F., Petruk, A.A., Modenutti, C.P., Dumas, V.G., Marti, M.A., Turjanski, A.G., WATCLUST: a tool for improving the design of drugs based on protein-water interactions (2015) Bioinformatics, 31, pp. 3697-3699 | ||
| 520 | 3 | |a Tuberculosis (TB) is a chronic disease caused by the bacillus Mycobacterium tuberculosis(Mtb) and remains a leading cause of mortality worldwide. The bacteria has an external wall which protects it from being killed, and the enzymes involved in the biosynthesis of the cell wall components have been proposed as promising targets for future drug development efforts. Cyclopropane Mycolic Acid Synthases (CMAS) constitute a group of ten homologous enzymes which belong to the mycolic acid biosynthesis pathway. These enzymes have S-adenosyl-L-methionine (SAM) dependent methyltransferase activity with a peculiarity, each one of them has strong substrate selectivity and reaction specificity, being able to produce among other things cyclopropanes or methyl-alcohol groups from the lipid olefin group. How each CMAS processes its substrate and how the specificity and selectivity are encoded in the protein sequence and structure, is still unclear. In this work, by using a combination of modeling tools, including comparative modeling, docking, all-atom MD and QM/MM methodologies we studied in detail the reaction mechanism of cmaA2, mmaA4, and mmaA1 CMAS and described the molecular determinants that lead to different products. We have modeled the protein-substrate complex structure and determined the free energy pathway for the reaction. The combination of modeling tools at different levels of complexity allows having a complete picture of the CMAS structure-activity relationship. © 2017 Elsevier Inc. |l eng | |
| 593 | |a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes, Ciudad Autónoma de Buenos Aires, 2620, Argentina | ||
| 593 | |a IQUIBICEN-UBA/CONICET, Intendente Güiraldes, Ciudad Autónoma de Buenos Aires, 2620, Argentina | ||
| 690 | 1 | 0 | |a BIOINFORMATICS |
| 690 | 1 | 0 | |a CMAS |
| 690 | 1 | 0 | |a METHYLTRANSFERASE |
| 690 | 1 | 0 | |a MYCOLIC ACIDS |
| 690 | 1 | 0 | |a QM/MM |
| 690 | 1 | 0 | |a BACTERIAL ENZYME |
| 690 | 1 | 0 | |a CYCLOPROPANE MYCOLIC ACID SYNTHASE |
| 690 | 1 | 0 | |a PROTEIN CMAA2 |
| 690 | 1 | 0 | |a PROTEIN MMAA1 |
| 690 | 1 | 0 | |a PROTEIN MMAA4 |
| 690 | 1 | 0 | |a UNCLASSIFIED DRUG |
| 690 | 1 | 0 | |a BACTERIAL PROTEIN |
| 690 | 1 | 0 | |a BICARBONATE |
| 690 | 1 | 0 | |a CYCLOPROPANE |
| 690 | 1 | 0 | |a CYCLOPROPANE DERIVATIVE |
| 690 | 1 | 0 | |a METHYLTRANSFERASE |
| 690 | 1 | 0 | |a MIXED FUNCTION OXIDASE |
| 690 | 1 | 0 | |a MMA4 PROTEIN, MYCOBACTERIUM TUBERCULOSSIS |
| 690 | 1 | 0 | |a AMINO ACID SEQUENCE |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a COMPARATIVE STUDY |
| 690 | 1 | 0 | |a ENERGY |
| 690 | 1 | 0 | |a ENZYME ACTIVITY |
| 690 | 1 | 0 | |a ENZYME MECHANISM |
| 690 | 1 | 0 | |a ENZYME STRUCTURE |
| 690 | 1 | 0 | |a ENZYME SUBSTRATE COMPLEX |
| 690 | 1 | 0 | |a MOLECULAR DOCKING |
| 690 | 1 | 0 | |a MOLECULAR MODEL |
| 690 | 1 | 0 | |a MYCOBACTERIUM TUBERCULOSIS |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a STRUCTURE ACTIVITY RELATION |
| 690 | 1 | 0 | |a CHEMISTRY |
| 690 | 1 | 0 | |a ENZYME ACTIVE SITE |
| 690 | 1 | 0 | |a ENZYMOLOGY |
| 690 | 1 | 0 | |a METABOLISM |
| 690 | 1 | 0 | |a MOLECULAR DYNAMICS |
| 690 | 1 | 0 | |a MYCOBACTERIUM TUBERCULOSIS |
| 690 | 1 | 0 | |a STRUCTURE ACTIVITY RELATION |
| 690 | 1 | 0 | |a BACTERIAL PROTEINS |
| 690 | 1 | 0 | |a BICARBONATES |
| 690 | 1 | 0 | |a CATALYTIC DOMAIN |
| 690 | 1 | 0 | |a CYCLOPROPANES |
| 690 | 1 | 0 | |a METHYLTRANSFERASES |
| 690 | 1 | 0 | |a MIXED FUNCTION OXYGENASES |
| 690 | 1 | 0 | |a MODELS, MOLECULAR |
| 690 | 1 | 0 | |a MOLECULAR DOCKING SIMULATION |
| 690 | 1 | 0 | |a MOLECULAR DYNAMICS SIMULATION |
| 690 | 1 | 0 | |a MYCOBACTERIUM TUBERCULOSIS |
| 690 | 1 | 0 | |a STRUCTURE-ACTIVITY RELATIONSHIP |
| 650 | 1 | 7 | |2 spines |a TUBERCULOSIS |
| 700 | 1 | |a Osman, F. | |
| 700 | 1 | |a Marti, M.A. | |
| 700 | 1 | |a Turjanski, A.G. | |
| 773 | 0 | |d Elsevier B.V., 2018 |g v. 498 |h pp. 288-295 |k n. 2 |p Biochem. Biophys. Res. Commun. |x 0006291X |w (AR-BaUEN)CENRE-905 |t Biochemical and Biophysical Research Communications | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028689177&doi=10.1016%2fj.bbrc.2017.08.119&partnerID=40&md5=5b9e75720b0d1ff6521b06e8c504c50a |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bbrc.2017.08.119 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_0006291X_v498_n2_p288_Defelipe |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0006291X_v498_n2_p288_Defelipe |y Registro en la Biblioteca Digital |
| 961 | |a paper_0006291X_v498_n2_p288_Defelipe |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 963 | |a VARI | ||
| 999 | |c 78003 | ||